Campbell Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.91M Buy
2,470
+2,150
+672% +$1.78M 0.17% 22
2024
Q3
$284K Buy
+320
New +$288K 0.03% 56
2024
Q2
Sell
-2,462
Closed -$1.92M 72
2024
Q1
$1.92M Sell
2,462
-85
-3% -$60.5K 0.19% 23
2023
Q4
$1.49M Buy
2,547
+1,724
+209% +$1.01M 0.18% 25
2023
Q3
$442K Buy
823
+63
+8% +$32.5K 0.05% 40
2023
Q2
$356K Hold
760
0.05% 43
2023
Q1
$261K Sell
760
-10
-1% -$3.37K 0.03% 56
2022
Q4
$282K Sell
770
-4
-0.5% -$1.42K 0.04% 58
2022
Q3
$250K Buy
+774
New +$245K 0.04% 62
2022
Q2
Sell
-760
Closed -$218K 63
2022
Q1
$218K Hold
760
0.03% 74
2021
Q4
$210K Buy
+760
New +$193K 0.02% 76
2020
Q3
Sell
-760
Closed -$125K 227
2020
Q2
$125K Buy
+760
New +$117K 0.02% 80

Other funds holding LLY

Campbell Wealth Management's LLY Position: Q4 2024 in Review

Campbell Wealth Management increased its Eli Lilly (LLY) stake by 672% in Q4 2024, buying an estimated $1.78M and bringing the position to 2,470 shares worth $1.91M. The position accounts for 0.17% of the portfolio, ranked #22.

Campbell Wealth Management first reported a position in LLY in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.92M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Campbell Wealth Management held 2,470 shares of Eli Lilly worth $1.91M as of Q4 2024.
  • Campbell Wealth Management bought 2,150 Eli Lilly shares in Q4 2024, an estimated $1.78M.
  • Eli Lilly made up 0.17% of Campbell Wealth Management's portfolio in Q4 2024, its #22 holding.
  • Campbell Wealth Management first reported a position in Eli Lilly in Q2 2020 and has held it in 12 quarters since.
  • Campbell Wealth Management's Eli Lilly position peaked at $1.92M in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Campbell Wealth Management's 13F filing for Q4 2024, filed 30 Jan 2025.